Tiba Biotech

Tiba Biotech Overview

Founded 2016
Status Private
Latest Deal Type Seed

Tiba Biotech General Information


Owner and operator of a pre-clinical stage biotechnology company intended to offer effective and affordable generation of nucleic acid products for human and animal health. The company offers RNA vaccine platform which is an engineered replicon payload capable of targeted antigen expression and rapid on-demand production of a new generation of safer vaccines against multiple diseases, enabling clients to access their technology for vaccines and immunotherapies for human and animal disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Other Software
Other Healthcare Technology Systems
Primary Office
  • 1 Broadway
  • 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tiba Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round Completed Startup

Tiba Biotech Executive Team (5)

Name Title Board Seat Contact Info
Karl Ruping JD Chief Executive Officer
Peter McGrath Chief Financial Officer
Christian Mandl Ph.D Co-Founder & Chairman
Jasdave Chahal Ph.D Co-Founder
Omar Khan Ph.D Co-Founder

Tiba Biotech Board Members (1)

Name Representing Role Since
Christian Mandl Ph.D Tiba Biotech Co-Founder & Chairman 000 0000

Ready to get started?

Request a free trial